Concepedia

Michele Senni

MS

7

Publications

7.6K

Citations

7

H-Index

2018

Active since

Affiliations

Ospedale Papa Giovanni XXIII(Current)

University Hospital Leipzig

Novartis (Switzerland)

Novartis (United States)

German Centre for Cardiovascular Research

Michele Senni is an author at Ospedale Papa Giovanni XXIII specializing in valvular heart disease, pharmacotherapy, and cardiovascular disease.

Top concepts

Publications per year

2018–2021

7

Publications

7

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Milton Packer, Stefan D. Anker, Javed Butler et al. · New England Journal of Medicine · 2020 · 4.7K citations · Full text

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Inder S. Anand et al. · New England Journal of Medicine · 2019 · 2.2K citations · Full text

Initiation of Sacubitril/Valsartan in Haemodynamically Stabilised Heart Failure Patients in Hospital or Early After Discharge: Primary Results of the Randomised TRANSITION Study

Rolf Wachter, Michele Senni, Jan Bělohlávek et al. · European Journal of Heart Failure · 2019 · 347 citations · Full text

Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction

Burkert Pieske, Rolf Wachter, Sanjiv J. Shah et al. · JAMA · 2021 · 155 citations · Full text

Initiation of Sacubitril/Valsartan Shortly After Hospitalisation for Acutely Decompensated Heart Failure in Patients with Newly Diagnosed ( <i>de novo</i> ) Heart Failure: A Subgroup Analysis of the TRANSITION Study

Michele Senni, Rolf Wachter, Klaus K. Witte et al. · European Journal of Heart Failure · 2019 · 64 citations · Full text

Rows per page

1–5 of 7